To view the PDF file, sign up for a MySharenet subscription.
Back to ACT SENS
AFRO-C:  130   -3 (-2.26%)  30/12/2025 15:24

AFROCENTRIC INVESTMENT CORPORATION LIMITED - Dealing in securities by a director of a major subsidiary

Release Date: 30/12/2025 09:35
Code(s): ACT     PDF:  
Wrap Text
Dealing in securities by a director of a major subsidiary

AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
("AfroCentric" or "the Company")

DEALING IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY

In compliance with paragraphs 3.63 of the JSE Limited Listings Requirements, the Company hereby
discloses the following dealings in securities by a director of a major subsidiary of AfroCentric:

 Name of Director:                           Fezeka Nompumza

 Designation:                                Executive Director of Medscheme, a major subsidiary of
                                             AfroCentric

 Date of transaction:                        23 December 2025

 Nature of transaction:                      On-market disposal

 Class of securities:                        Ordinary shares

 Number of securities:                       128 333

 Highest traded price per security on the
 market on the day:                          R1.47

 Weighted average price per security:        R1.3416

 Lowest traded price per security on the
 market on the day:                          R1.24

 Value of transaction:                       R172 171.55

 Nature of interest:                         Direct Beneficial

 Clearance obtained:                         Yes



Johannesburg
30 December 2025

JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited

Date: 30-12-2025 09:35:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.